Suzuken Past Earnings Performance
Past criteria checks 4/6
Suzuken's earnings have been declining at an average annual rate of -0.6%, while the Healthcare industry saw earnings growing at 6.9% annually. Revenues have been growing at an average rate of 2.2% per year. Suzuken's return on equity is 7.3%, and it has net margins of 1.3%.
Key information
-0.6%
Earnings growth rate
2.7%
EPS growth rate
| Healthcare Industry Growth | 7.9% |
| Revenue growth rate | 2.2% |
| Return on equity | 7.3% |
| Net Margin | 1.3% |
| Next Earnings Update | 12 Nov 2024 |
Recent past performance updates
Recent updates
Calculating The Intrinsic Value Of Suzuken Co., Ltd. (TSE:9987)
Sep 05
Subdued Growth No Barrier To Suzuken Co., Ltd.'s (TSE:9987) Price
Jul 11Here's Why We Think Suzuken (TSE:9987) Is Well Worth Watching
Jun 12Shareholders Can Be Confident That Suzuken's (TSE:9987) Earnings Are High Quality
May 22Investor Optimism Abounds Suzuken Co., Ltd. (TSE:9987) But Growth Is Lacking
Mar 22Revenue & Expenses Breakdown
How Suzuken makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 2,395,045 | 30,636 | 151,807 | 0 |
| 31 Mar 24 | 2,386,493 | 29,016 | 150,373 | 0 |
| 31 Dec 23 | 2,371,225 | 27,681 | 148,999 | 0 |
| 30 Sep 23 | 2,370,990 | 25,379 | 148,235 | 0 |
| 30 Jun 23 | 2,334,718 | 21,006 | 148,283 | 0 |
| 31 Mar 23 | 2,314,828 | 20,345 | 147,089 | 0 |
| 31 Dec 22 | 2,306,580 | 19,310 | 148,224 | 0 |
| 30 Sep 22 | 2,273,513 | 16,065 | 147,618 | 0 |
| 30 Jun 22 | 2,247,385 | 17,506 | 146,832 | 0 |
| 31 Mar 22 | 2,232,774 | 14,393 | 147,216 | 0 |
| 31 Dec 21 | 2,205,199 | 15,033 | 146,186 | 0 |
| 30 Sep 21 | 2,183,487 | 12,694 | 146,138 | 0 |
| 30 Jun 21 | 2,150,734 | 9,041 | 146,954 | 0 |
| 31 Mar 21 | 2,128,218 | 7,895 | 148,683 | 0 |
| 31 Dec 20 | 2,133,976 | 14,012 | 151,976 | 0 |
| 30 Sep 20 | 2,141,519 | 19,394 | 156,093 | 0 |
| 30 Jun 20 | 2,183,542 | 22,641 | 159,183 | 0 |
| 31 Mar 20 | 2,213,478 | 28,213 | 161,552 | 0 |
| 31 Dec 19 | 2,214,475 | 26,263 | 161,696 | 0 |
| 30 Sep 19 | 2,214,861 | 34,177 | 162,139 | 0 |
| 30 Jun 19 | 2,159,354 | 33,533 | 162,114 | 0 |
| 31 Mar 19 | 2,132,362 | 30,204 | 162,066 | 0 |
| 31 Dec 18 | 2,111,244 | 28,126 | 162,386 | 0 |
| 30 Sep 18 | 2,108,847 | 20,925 | 164,145 | 0 |
| 30 Jun 18 | 2,115,937 | 16,386 | 165,567 | 0 |
| 31 Mar 18 | 2,123,997 | 18,820 | 167,775 | 0 |
| 31 Dec 17 | 2,130,453 | 18,807 | 170,795 | 0 |
| 30 Sep 17 | 2,118,731 | 21,894 | 172,177 | 0 |
| 30 Jun 17 | 2,121,761 | 23,333 | 173,352 | 0 |
| 31 Mar 17 | 2,126,993 | 21,308 | 174,513 | 0 |
| 31 Dec 16 | 2,186,665 | 26,534 | 175,576 | 0 |
| 30 Sep 16 | 2,247,810 | 26,403 | 176,048 | 0 |
| 30 Jun 16 | 2,251,839 | 26,925 | 175,510 | 0 |
| 31 Mar 16 | 2,228,331 | 28,960 | 174,219 | 0 |
| 31 Dec 15 | 2,149,121 | 24,043 | 171,592 | 0 |
| 30 Sep 15 | 2,066,204 | 21,320 | 169,118 | 0 |
| 30 Jun 15 | 2,017,824 | 20,122 | 167,536 | 0 |
| 31 Mar 15 | 1,969,689 | 18,920 | 166,390 | 0 |
| 31 Dec 14 | 1,977,291 | 21,296 | 167,098 | 0 |
| 30 Sep 14 | 1,968,911 | 20,219 | 167,656 | 0 |
| 30 Jun 14 | 1,968,813 | 19,905 | 167,391 | 0 |
| 31 Mar 14 | 1,988,216 | 21,447 | 168,216 | 0 |
| 31 Dec 13 | 1,952,023 | 22,495 | 165,910 | 0 |
| 30 Sep 13 | 1,933,492 | 21,252 | 164,826 | 0 |
Quality Earnings: 9987 has high quality earnings.
Growing Profit Margin: 9987's current net profit margins (1.3%) are higher than last year (0.9%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 9987's earnings have declined by 0.6% per year over the past 5 years.
Accelerating Growth: 9987's earnings growth over the past year (45.8%) exceeds its 5-year average (-0.6% per year).
Earnings vs Industry: 9987 earnings growth over the past year (45.8%) exceeded the Healthcare industry 8.2%.
Return on Equity
High ROE: 9987's Return on Equity (7.3%) is considered low.